Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
A patient-derived CTC culture assay for anticancer drug evaluation to guide therapy for personalized treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 Assay validation with controls. (A) Screening of doxorubicin in microwell assay using MCF-7 cancer cell line. Cultures were imaged in situ after staining with LIVE (calcein-AM; green) and DEAD [ethidium bromide (EtBr); red] under 72 hours of exposure to doxorubicin. Clusters under high drug concentrations are mostly nonviable (red), whereas clusters under low drug concentrations are mostly viable (green). (B) Dose-response curve and corresponding IC50 value (0.78 ± 0.02 μM) of MCF-7 generated from viability results. Representative image shows an MCF-7 cell cluster within a microwell (inset). Scale bars, 50 mm. (C) Scatterplot demonstrating overall high gray values that reflect the absence of clusters from cultures of blood from healthy volunteers. Representative image shows cell debris generated within a microwell from culture of a healthy sample (inset). Scale bars, 50 mm.](https://figures.cochat.ai/paper-figures/7e88543c7fea46f48aab4f2c301110a5/liquid-biopsy-and-therapeutic-response-circulating-tumor-cell-cultures-for-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“composite collagen‐alginate microcapsules laden with breast cancer cells (MCF‐7) were reported to create 3D vascularized tumor spheroids by suspending these core–shell microbeads inside an external stromal cell‐laden collagen matrix”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [72]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fortunately, with the development of biofabrication techniques, microfluidic and 3D bioprinting technologies have been employed to create more in vivo‐like perfusable 3D tumor models in the biomimetic matrix.[ 72 , 161 ]”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Such heterogeneity is observed in the cohort of circulating tumor cells (CTCs) [12,13], which can be isolated from the peripheral bloodstream or cultured for further analyses.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“Formation of cell clusters in the microwells was shown to be inversely correlated with increased drug concentration and therapeutic treatment and this liquid biopsy technique can potentially be used to develop personalized medicine.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [135]
The cited source says what the claim attributes to it.
In the citing paper
“Formation of cell clusters in the microwells was shown to be inversely correlated with increased drug concentration and therapeutic treatment and this liquid biopsy technique can potentially be used to develop personalized medicine.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [135]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628 · cited 1×
“However, the markers used for CTC detection are not applicable to all its subpopulations (32), partly due to the process of epithelial-tomesenchymal transition (36).”
BackgroundSelf-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367 · cited 2×
“This is a similar observation that has been suggested in previous reports for tumor-associatedmacrophages (22).”
ResultCirculating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Continuous inertial focusing, ordering, and separation of particles in microchannels
Di Carlo, D., Irimia, D., Tompkins, R. G., & Toner, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704958104 · Cited by 1,708
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc882 · Cited by 1,656 · cited 1×
“Current imaging techniques for cancer evaluation [for example, computed tomography (CT) scan] also suffer from technical limitations (3, 4), which lead to false-negative findings.”
Method
Research works printed but not linked: 2
- 10.1111/j.1572-0241.2000.02091.x · doi:10.1111/j.1572-0241.2000.02091.x · Paper page
- I. J. Fidler, Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2’-deoxyuridine. J. Natl. Cancer Inst. 45, 773–782 (1970).
Cited by
Items 101–147 of 147
Circulating Tumor Cells in the Parallel Invasion Model Supporting Early Metastasis
Hamilton, G., & Rath, B. (2017) · Oncomedicine · doi:10.7150/oncm.22576 · Cited by 10
“[15, 36, 37] However, to identify the CTCs which have the potential to initiate metastases and to find means to interfere with this process is extremely difficult.”
BackgroundIdentification of Cancer-Associated Circulating Cells in Anal Cancer Patients
Carter, T. J., Jeyaneethi, J., Kumar, J., Karteris, E., Glynne‐Jones, R., & Hall, M. (2020) · Cancers · doi:10.3390/cancers12082229 · Cited by 7
“Assessment of circulating cells from liquid biopsies are an emerging technology which could provide valuable information on treatment failure, before recurrence disease is clearly evident via cross-sectional imaging [15].”
BackgroundMicrodevices for Non-Invasive Detection of Bladder Cancer
Tzouanas, C. N., Lim, J., Wen, Y., Thiery, J. P., & Khoo, B. (2017) · Chemosensors · doi:10.3390/chemosensors5040030 · Cited by 8
Self-citationA miniaturized device for biomembrane permeation analysis
Ding, D., Pan, J., Yeo, S. H., Wagholikar, V. V., Lim, S. H., Wu, C., Fuh, J. Y. H., & Kang, L. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.109772 · Cited by 8
Wang, Z., & Chen, K. (2023) · Brain‐X · doi:10.1002/brx2.33 · Cited by 7
Origin, Metastasis, Harm, Recognition and Capture, and Elimination of Circulating Tumor Cells
Yuan, Q., Chen, L., Wan, M., Mao, C., & Shen, J. (2024) · Advanced Materials Technologies · doi:10.1002/admt.202301306 · Cited by 7
Cui, M., Chen, X., Luo, X., Zhou, Z., Chen, Z., Zhou, Z., Zhou, X., Zou, H., Xu, T., Wang, S., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114692 · Cited by 7
Drug susceptibility testing of circulating lung cancer cells for personalized treatment
Balakrishnan, A., Thottian, A. G. F., Babu, K. G., & Kumar, P. (2022) · Medical Oncology · doi:10.1007/s12032-022-01860-3 · Cited by 7
“reported the IC50 of the CTCs treated with the drug in vitro prior to the patient’s treatment was less than that of post-treatment [24].”
BackgroundModels to study CTCs and CTC culture methods
Fernández-Santiago, C., López‐López, R., & Piñeiro, R. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.07.007 · Cited by 9
Advancing Techniques and Insights in Circulating Tumor Cell (CTC) Research
Khoo, B. L., Chaudhuri, P. K., Lim, C. T., & Warkiani, M. E. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-45397-2_5 · Cited by 11
Self-citationNew initiatives in the treatment of breast cancer
Olver, I. (2016) · The Medical Journal of Australia · doi:10.5694/mja16.01055 · Cited by 7
Li, W., Zhang, J., Liao, J., Zhu, M., Wang, X., Zhou, X., Ma, Z., Hilal, M. E., Chua, S. L., Tan, G., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00930 · Cited by 6
Self-citationBreast tumor-on-chip: from the tumor microenvironment to medical applications
Liu, Y., Liu, R., Liu, H., Lyu, T., Chen, K., Jin, K., & Tian, Y. (2023) · The Analyst · doi:10.1039/d3an01295f · Cited by 6
Jou, H., Ho, H.-C., Huang, K.-Y., Chen, C., Chen, S.-W., Lo, P.-H., Huang, P., Huang, C.-E., & Chen, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315139 · Cited by 7
Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices
Mariani, S., Bertero, L., Coppola, V., Saracco, G. M., Arezzo, A., di Celle, P. F., Metović, J., Marchiò, C., & Cassoni, P. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1468254 · Cited by 6
“…tumor and plasma DNA samples from patients with breast cancer (Bettegowda et al., 2014; Higgins et al., 2012; Dawson et al., 2013), colorectal cancer (Diehl et al., 2008; Misale et al., 2012, Thierry et al., 2014), and non-small cell lung cancer (NSCLC) (Narayan et al., 2012; Khoo et al., 2016).”
BackgroundJeong, Y. J., Park, S.-M., & Jeon, C. (2020) · Oncology Letters · doi:10.3892/ol.2020.11939 · Cited by 10
Hamilton, G., & Rath, B. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2016.57 · Cited by 6
“Attempts have been made to characterize the chemosensitivity of CTCs in short term cultures in various tumor entities.[46] However, CTCs are specialized cells different from the tumor bulk and most likely also”
BackgroundMicroslit on a chip: A simplified filter to capture circulating tumor cells enlarged with microbeads
Lee, S. J., Sim, T. S., Shin, H. Y., Lee, J., Kim, M. Y., Sunoo, J., Lee, J., Yea, K., Kim, Y. Z., van Noort, D., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223193 · Cited by 6
Self-citationDai, J., Cai, B., Zhang, Y., Zhao, S., Zhao, X., Wang, G., Wang, L., & Wang, Z. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202201584 · Cited by 5
Circulating Tumor Cells Culture: Methods, Challenges, and Clinical Applications
Zhou, Z., Cai, S., Zhou, X., Zhao, W., Sun, J., Zhou, Z., Yang, Z., Li, W., Wang, Z., Zou, H., et al. (2024) · Small Methods · doi:10.1002/smtd.202401026 · Cited by 6
Self-citationMiyamukai, H., Yagi, I., Uchida, S., Takano, M., Wakizaka, Y., & Enjoji, T. (2021) · Electronics and Communications in Japan · doi:10.1002/ecj.12328 · Cited by 5
Kulasinghe, A., Warkiani, M. E., & Punyadeera, C. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9769-5_8 · Cited by 5
Al‐Khreisat, M. J., Abosaoda, M. K., Ibrahim, N. A., Malathi.H, M., Priyadarshini‐Nayak, P., Sathiya‐Priya, V., Singh, G., & Chauhan, A. S. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70197 · Cited by 3
“Nonetheless, the detection rates and sensitivities of CTC assays vary significantly, both across different technological platforms and between studies using comparable methodologies [25–27].”
Investigation of tumour environments through advancements in microtechnology and nanotechnology
Liu, Z., Fan, Y. L., Cui, M., Wang, X., & Zhao, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117230 · Cited by 4
A Vicsek-type model of confined cancer cells with variable clustering affinities
Kirchner, Z., Geohagan, A., & Truszkowska, A. (2024) · Integrative Biology · doi:10.1093/intbio/zyae005 · Cited by 3
Chen, S., Heliebi, A. E., & Kroneis, T. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.06.001 · Cited by 4
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017
Okunieff, P. G., Casey‐Sawicki, K., Lockney, N. A., Hoppe, B. S., Enderling, H., Pinnix, C. C., Welsh, J. D., Krishnan, S., Yothers, G., Brown, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3202 · Cited by 3
Prasanna, B. K., Balakrishnan, A., & Kumar, P. (2020) · BioTechniques · doi:10.2144/btn-2020-0029 · Cited by 3
Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility
Alam, M. K., Yanjun, L., Khoo, B. L., Si, T., Zou, H., & Yang, M. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400438 · Cited by 4
Self-citationDezauzier, R., Fomina, A., & Dittrich, P. S. (2025) · Lab on a Chip · doi:10.1039/d5lc00210a · Cited by 2
Jiang, Y., Hao, M., Chen, S., Xie, Y., & Liu, K. (2024) · Analytical Methods · doi:10.1039/d4ay01343c · Cited by 3
Rapid Recovery and Short‐Term Culture of Gastric Circulating Tumor Cells Using Microcavity Array
Yoshino, T., Takabayashi, T., Bao, Q., Tanaka, T., Negishi, R., Shimoyama, T., Sawada, T., Kanemasa, Y., & Koizumi, F. (2025) · Engineering in Life Sciences · doi:10.1002/elsc.70026 · Cited by 2
“Their findings suggest that CTC detection could be an independent predictor of prognosis in gastric cancer, particularly DFS. Khoo et al. [10] used patient-derived CTC cultures obtained from liquid biopsies to form CTC clusters using microwells and microfluidics for in situ drug screening.”
Amin, A. T., Shiraishi, N., & Kitano, S. (2018) · Journal of Hematology and Oncology Research · doi:10.14302/issn.2372-6601.jhor-18-2396 · Cited by 1
Place des biopsies liquides dans le diagnostic et la caractérisation moléculaire des cancers du sein
Vion, R., Fontanilles, M., Fiore, F. D., & Clatot, F. (2021) · Bulletin du Cancer · doi:10.1016/s0007-4551(21)00636-6 · Cited by 1
Wong, F., Khoo, B. L., & Chan, K. K. L. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5006132 · Cited by 1
Self-citationLiu, Y., & Wang, W. (2022) · Micromachines · doi:10.3390/mi13020209 · Cited by 1
Circulating Tumour Cells in Head and Neck Cancers
Kulasinghe, A. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.110534
Advances in Ex vivo Cell Screening Methodologies for Clinical Therapy Guidance to Leukemic Patients
Kulkarni, A. (2018) · Developments in Clinical & Medical Pathology · doi:10.31031/dcmp.2018.01.000504
“[4] have developed a novel approach to evaluate patient drug response ex vivo using patient blood-derived circulating tumor cell (CTC) cultures in an integrated micro fluidic system incorporating micro-fabricated micro-wells.”
Microfluidic Chip-Based Live Single-Cell Probes
Mao, S., & Lin, J. (2019) · Integrated analytical systems · doi:10.1007/978-981-32-9729-6_9
Miyamukai, H., Yagi, I., Uchida, S., Takano, M., Wakizaka, Y., & Enjoji, T. (2021) · IEEJ Transactions on Sensors and Micromachines · doi:10.1541/ieejsmas.141.179
Circulating tumour cells in non-small cell lung cancer
Kapeleris, J. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.228607
Tissue-engineered Cancer Models in Drug Screening
Cao, R., Fomina, A., & McGuigan, A. P. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00415
Are we ready to endorse new multiple cancer early-detection tests?
Felix Wu Shun, W. O. N. G., & Khoo, B. L. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.17.2.0325
“There are also efforts to introduce label-free technologies to identify patients at high cancer risk based on proliferative capabilities (9), biochemical cues (11), and physical attributes (4) to complement conventional screens with automated analysis for robust and high throughput screening (8).”
Self-citationExploring the Role of Circulating Tumor Cells in Contralateral Neck Metastasis
Varsha, B., Thakur, S., Sindhe, J. R., Rao, V. U. S., Subash, A., Joy, A., Puthiyottil, I. V., Bylapudi, B., Maruthi, M., & Mishra, S. (2024) · Journal of Head & Neck Physicians and Surgeons · doi:10.4103/jhnps.jhnps_49_24
Wang, Y., Wang, M., Liu, M., Chen, Y., Xu, L., Zhou, J., Wang, F., Cheng, S., Xie, M., & Huang, W. (2026) · Advanced Science · doi:10.1002/advs.202511148
Zalawadia, D. H., Bhate, V., Chakravarthy, T. D., Chetty, A. G., & Ray, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727079
Metadata
- Authors
- Khoo, B. L., Grenci, G., Jing, T., Lim, Y. B., Lee, S. C., Thiery, J. P., Han, J., & Lim, C. T.
- Affiliations
- Singapore-MIT Alliance for Research and Technology (SG)
- National University of Singapore (SG)
- Corresponding author
- Lim, Chwee Teck
- ORCID
- Venue
- Science Advances
- Published
- 2016-07
- Volume
- 2
- Issue
- 7
- Pages
- e1600274-e1600274
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4956185
- OpenAlex
- W2471117482
- Semantic Scholar
- 4a72640c1b8899f148e8da40a9f771600369426d
- Cited by
- 147
- References
- 52
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 19 · 2022: 21 · 2021: 11 · 2020: 19 · 2019: 22 · 2018: 14 · 2017: 15 · 2016: 4
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Science Advances (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Mechanobiology Institute (ID0ETJBI8533)
- Singapore-MIT Alliance for Research and Technology (ID0EXPBI8534)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- liquid biopsy, circulating tumor cells, CTC clusters, drug response monitoring, anticancer drug screening, metastatic breast cancer, microfluidics, drug resistance, precision oncology
- MeSH terms
- Antineoplastic Agents, Biopsy, Breast Neoplasms, Doxorubicin, Female, Humans, Neoplastic Cells, Circulating, Neoplasm Metastasis, Tumor Cells, Cultured, In Situ Hybridization, Fluorescence, Cell Culture Techniques, Microfluidic Analytical Techniques, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.